The National University Health System (NUHS) has marked a major milestone in the Singapore’s healthcare transformation with the official launch of the National University Centre for Genomic Medicine (NUGEM), reinforcing Singapore’s commitment to integrating genomics into everyday clinical care.
The initiative, launched during the NUHS Scientific and Innovation Summit 2026, was officiated by Mr Heng Swee Keat, Chairman of the National Research Foundation. Rather than being tied to a single monthly announcement or symbolic date such as April, the launch represents an ongoing, operational shift in healthcare delivery, with immediate and long-term integration into clinical practice.
A new model of care powered by genomics
NUGEM brings together a multidisciplinary team of clinical and laboratory geneticists, specialist clinicians, genetic counsellors, pathologists, researchers, and digital health experts. Based within the National University Hospital, the centre connects expertise across multiple institutions including NUH, NTFGH, Alexandra Hospital, NCIS, NUHCS, and NUS Medicine.
The centre’s goal is to embed genomic testing into routine care — not only for rare genetic disorders, but also across oncology, cardiology, nephrology, infectious diseases, neurology, and primary care.
“This is about transforming genomics from specialist use into everyday medicine,” said Associate Professor Ng Kar Hui, Director of NUGEM. “Genomic insights should be available where care happens, enabling faster, safer and more precise decisions.”
From research to real patients
Genomics is already influencing patient care across NUHS, supporting earlier diagnoses, more targeted therapies, and improved family planning decisions. Examples include:
- Rapid ICU genetic testing identifying previously unknown immune defects, enabling life-saving treatment adjustments
- Couples using genetic screening and IVF with pre-implantation testing to prevent inherited diseases
- Identification of hidden kidney disorders, allowing early intervention and family risk management
- New sequencing technologies reducing diagnostic timelines from weeks to under 24 hours in infectious disease cases
Safer prescribing through pharmacogenomics
A key pillar of the initiative is pharmacogenomics, where a patient’s genetic profile helps guide medication choices and dosing. With over 99% of local patients carrying genetic variants affecting drug response, NUHS aims to scale pre-emptive testing to reduce adverse drug reactions and improve treatment effectiveness.
A long-term shift in healthcare
Experts estimate that within the next two decades, up to one-third of clinical encounters in NUHS may involve genomics or precision medicine discussions.
Beyond genomics, the summit also highlighted broader innovation efforts in digital health, preventive care, ageing science, and antimicrobial resistance.
“As we scale these tools across the system, the goal remains simple: to deliver the right care at the right time, guided by the best possible insight,” said Associate Professor David Tan, Co-Chair of the Summit Organising Committee.
13.05.2026.
